Infections and infestations of the skin in children

Paediatrics and Child Health

Volumn 17, Issue 10, 2007, Pages 400-406

  Tomson, Nevianna ^a,b   Sterling, Jane C ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

bacteria; fungus; infection; infestation; paediatrics; skin; virus

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN; CLOTRIMAZOLE; CROTAMITON; ERYTHROMYCIN; FAMCICLOVIR; FLUCLOXACILLIN; FUSIDIC ACID; GLUTARALDEHYDE; GRISEOFULVIN; IVERMECTIN; KETOCONAZOLE; NYSTATIN; PSEUDOMONIC ACID; SALICYLIC ACID; SULFUR; TERBINAFINE; VALACICLOVIR;

ARTICLE; BACTERIAL INFECTION; CANDIDIASIS; CHILD CARE; CHILDHOOD DISEASE; HAND FOOT AND MOUTH DISEASE; HERPES; HERPES SIMPLEX; HERPES VIRUS; HERPES ZOSTER; HUMAN; IMPETIGO; IMPETIGO BULLOSA; INCIDENCE; MOLLUSCUM CONTAGIOSUM; MYCOSIS; NECROTIZING FASCIITIS; PEDICULOSIS; SCABIES; SKIN DISEASE; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TINEA CAPITIS; TINEA VERSICOLOR; TOXIC EPIDERMAL NECROLYSIS; TOXIC SHOCK SYNDROME; VERRUCA VULGARIS; VIRUS INFECTION;

EID: 34948855912     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.07.039     Document Type: Article

References (48)

1. Amagai M., Matsuyoshi N., Wang Z.H., et al. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 6 11 (2000) 1275-1277
2. Murray R.J. Recognition and management of Staphylococcus aureus toxin-mediated disease. Intern Med J 35 suppl 2 (2005) S106-S119
3. Chi C.Y., Wang S.M., Lin H.C., et al. A clinical and microbiological comparison of Staphylococcus aureus toxic shock and scalded skin syndromes in children. Clin Infect Dis 42 2 (2006) 181-185
4. Chuang Y.Y., Huang Y.C., and Lin T.Y. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs 7 1 (2005) 11-25
5. Legbo J.N., and Shehu B.B. Necrotising fasciitis: experience with 32 children. Ann Trop Paediatr 25 3 (2005) 183-189
6. Vayalumkal J.V., and Jadavji T. Children hospitalized with skin and soft tissue infections: a guide to antibacterial selection and treatment. Paediatr Drugs 8 2 (2006) 99-111
7. Fustes-Morales A., Gutierrez-Castrellon P., Duran-Mckinster C., et al. Necrotizing fasciitis: report of 39 pediatric cases. Arch Dermatol 138 7 (2002) 893-899
8. Weston W., Lane A., and Morelli J. Viral infections. Color Textbook of Pediatric Dermatology. 3rd edn. St Louis: (2002), Mosby 89-118
9. Committee on Infectious Diseases. American Academy of Pediatrics. Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village (2000)
10. Riley L.E. Herpes simplex virus. Semin Perinatol 22 4 (1998) 284-292
11. Jones V.F., Badgett J.T., and Marshall G.S. Repeated photoreactivation of herpes simplex virus type 1 in an extrafacial dermatomal distribution. Pediatr Infect Dis J 13 3 (1994) 238-239
12. ACOG. ACOG Practice bulletin: management of herpes in pregnancy. Clinical management guidelines for obstetrician-gynaecologists. Int J Gynaecol Obstet 68 (2000) 165
13. Stalkup J., Yeung-Yue K., Brentjens M., et al. Human herpesviruses. In: Bolognia J., Jorizzo J., and Rapini R. (Eds). Dermatology (2004), New York: Mosby 1235-1253
14. Whitley R. Herpes simplex virus infections. In: Remington J., and Klein J. (Eds). Infectious Diseases of the Fetus and Newborn Infant (1990), WB Saunders, Philadelphia 282-305
15. Arvin A. Chickenpox (varicella). Contrib Microbiol 3 (1999) 96-110
16. Kakourou T., Theodoridou M., Mostrou G., et al. Herpes zoster in children. J Am Acad Dermatol 39 2 part 1 (1998) 207-210
17. Ruiz-Maldonado R., Parish L., and Beare J. Textbook of Pediatric Dermatology (1989), Philadelphia: Grune & Stratton p. 441-61
18. Leslie K.S., Dootson G., and Sterling J.C. Topical salicylic acid gel as a treatment for molluscum contagiosum in children. J Dermatol Treat 16 5 (2005) 336-340
19. Verbov J., and Morley N. Colour Atlas of Paediatric Dermatology (1983), Lancaster: MTP Press 74
20. Paller A., and Mancini A.J. Skin disorders due to fungi. Hurwitz's Clinical Pediatric Dermatology. 3rd edn. Philadelphia: (2006), Elsevier Saunders 449-478
21. Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr Infect Dis J 18 2 (1999) 180-185
22. Friedlander S. Tinea capitis: past, present and future. Curr Probl Dermatol 12 (2000) 126
23. Tack D.A., Fleishcer Jr. A., McMichael A., et al. The epidemic of tinea capitis disproportionately affects school-aged African Americans. Pediatr Dermatol 16 1 (1999) 75
24. Hubbard T.W. The predictive value of symptoms in diagnosing childhood tinea capitis. Arch Pediatr Adolesc Med 153 11 (1999) 1150-1153
25. Clayton Y., and Moore M. Superficial fungal infections. In: Harper J., Oranje A., and Prose N. (Eds). Textbook of Pediatric Dermatology. 2nd edn. Oxford: (2006), Blackwell Publishing 542-569
26. Friedlander S.F. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis. Pediatr Infect Dis J 18 2 (1999) 205-210
27. Bennett M.L., Fleischer A.B., Loveless J.W., et al. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol 17 4 (2000) 304-309
28. Gupta A.K., Hofstader S.L., Adam P., et al. Tinea capitis: an overview with emphasis on management. Pediatr Dermatol 16 3 (1999) 171-189
29. Krafchik B., and Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. J Am Acad Dermatol 41 1 (1999) 60-63
30. Harris J., Crawshaw J.G., and Millership S. Incidence and prevalence of head lice in a district health authority area. Commun Dis Public Health 6 3 (2003) 246-249
31. Counahan M., Andrews R., Buttner P., et al. Head lice prevalence in primary schools in Victoria, Australia. J Paediatr Child Health 40 11 (2004) 616-619
32. Izri A., and Chosidow O. Efficacy of machine laundering to eradicate head lice: recommendations to decontaminate washable clothes, linens, and fomites. Clin Infect Dis 42 2 (2006) e9-e10
33. Kristensen M., Knorr M., Rasmussen A.M., et al. Survey of permethrin and malathion resistance in human head lice populations from Denmark. J Med Entomol 43 3 (2006) 533-538
34. Brand R.M., Charron A.R., and Brand R.E. Decreasing malathion application time for lice treatment reduces transdermal absorption. Int J Pharm 301 1-2 (2005) 48-53
35. Burkhart C.G., and Burkhart C.N. Head lice therapies revisited. Dermatol Online J 12 6 (2006) 3
36. Heukelbach J., Oliveira F.A., and Speare R. A new shampoo based on neem (Azadirachta indica) is highly effective against head lice in vitro. Parasitol Res 99 4 (2006) 353-356
37. Hill N., Moor G., Cameron M.M., et al. Single blind, randomised, comparative study of the Bug Buster kit and over the counter pediculicide treatments against head lice in the United Kingdom. BMJ 331 7513 (2005) 384-387
38. Roberts R.J., Casey D., Morgan D.A., et al. Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial. Lancet 356 9229 (2000) 540-544
39. Goates B.M., Atkin J.S., Wilding K.G., et al. An effective nonchemical treatment for head lice: a lot of hot air. Pediatrics 118 5 (2006) 1962-1970
40. Pearlman D.L. A simple treatment for head lice: dry-on, suffocation-based pediculicide. Pediatrics 114 3 (2004) e275-e279
41. Burgess I.F., Brown C.M., and Lee P.N. Treatment of head louse infestation with 4% dimeticone lotion: randomised controlled equivalence trial. BMJ 330 7505 (2005) 1423
42. Sasaki T., Poudel S.K., Isawa H., et al. First molecular evidence of Bartonella quintana in Pediculus humanus capitis (Phthiraptera: Pediculidae), collected from Nepalese children. J Med Entomol 43 1 (2006) 110-112
43. Heukelbach J., Wilcke T., Winter B., et al. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Dermatol 153 1 (2005) 150-156
44. Arlian L.G., Runyan R.A., Achar S., et al. Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol 11 2 part 1 (1984) 210-215
45. Taplin D., Meinking T.L., Porcelain S.L., et al. Permethrin 5% dermal cream: a new treatment for scabies. J Am Acad Dermatol 15 5 part 1 (1986) 995-1001
46. Taplin D., Meinking T.L., Chen J.A., et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 7 1 (1990) 67-73
47. Elgart M.L. Cost-benefit analysis of ivermectin, permethrin and benzyl benzoate in the management of infantile and childhood scabies. Expert Opin Pharmacother 4 9 (2003) 1521-1524
48. Victoria J., and Trujillo R. Topical ivermectin: a new successful treatment for scabies. Pediatr Dermatol 18 1 (2001) 63-65